Braveheart Bio to Host HCM Webinar on November 6
Braveheart Bio said it will host an investor webinar on hypertrophic cardiomyopathy, featuring a key opinion leader discussion. The company describes itself as developing therapies for HCM and other cardiovascular diseases.